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Uptake of [‘H]t-glutamate into menrbranc vesicles prepared from either mouse cortical astrocytc ultures or synaptosomes was found to bc an 
electrogenic sodium- and potassium-dependent transport process with saturable uptake kinetics. Pharmacological dilTerenccs were revealed by using 
a variety of substrate analogues. L-rmns-PDC inhibited the synaptosomal g utamate transport 2-4.fold stronger than the nstroglkl uptake. The 
substrate analogues DL-threo-p-hydroxy-asparlale, oL-aspartatc-IT-hydroxamate, L-aspartate and D-aspartatc inhibited glutamate transport of 
astroglial and neuronal membrane vesicles in a distinctive manner, whereas D-glutamate, quisqualate and dihydrokainutc had no effect in either 
case. lmmunoblotting and immunocytochemical labeling with antibodies against he rat brain glutamate transporter revealed the selective reaction 
of a band at about 75 kDa mol. wt. and a specific pattern ofastrocytc immunostaining. 
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1. INTRODUCTION 
The major part of the excitatory neurotransmission 
process in the mammalian central nervous system is 
mediated by the amino acid L-glutamate. Termination 
of such neuronal activity is brought about by a sodium- 
dependent high affinity uptake system. Although iso- 
lated nerve ending fractions are known to accumulate 
glutamate via a high affinity transport system [l-3], 
other biochemical evidence [4,5] suggests that uptake 
into astroglial cells may be of even greater importance 
in terminating transmitter action in the brain. Whilst in 
the past L-glutamate transport of neurons and astro- 
cytes for itself has been studied in brain slices, cell cul- 
tures or rat brain membrane preparations [6-81, a de- 
tailed comparative biochemical analysis of the synap 
tosomal and astroglial glutamate transport of the same 
brain region under identical conditions is still lacking. 
In particular, a closer pharmacological characterization 
of the respective substrate binding sites would be desir- 
able to obtain a better insight into the specific structural 
requirements and the basic features of either L-gluta- 
mate transport system. A most suitable experimental 
paradigm for a comparative approach of this kind is 
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membrane vesicle preparations derived either from cul- 
tured cortical astrocytes or synaptodomal fractions, 
which allow one to individually analyse each of the 
components involved in the transport process, including 
ionic dependence and pharmacological specificity, with- 
out metabolic interference from the cellular cytoplasm. 
In addition to this in the present s udy an immunochem- 
ical approach was made using antibodies recently gener- 
ated against a rat brain glutamate transporter [9]. 
2. MATERIALS AND METHODS 
9. I. Mureriais 
L-[‘H&Xnamalc (21-56 Ci/mmol), n-[‘HIglucose (20-30 Ci/mmol), 
ECL (enhanced chcmiluminescencc)-Western Blotting Detection Sys- 
tem and ECL-Hyperfilm were obtained from Amenham Buchler. 
Reagents for cell cultures, including Dulbecco’s Modified Eagle’s Me- 
dium, MEM HEPES, and fetal calf serum were from Gibco/BRL. 
PDC (L-rruns-pyrrolidine-2,4-dicarboxylic acid) was from Tocris Ncu- 
rnmin Ltd. D- and L-aspnrtic acid, ihydrokainic acid, D- and L-p$u- 
tamic acid, DL-threo-p-hydroxyaspartic cid, quisqualic acid, valino- 
mycin, nigericin, FITC- and TRlTC-conjugated secondary antihod- 
ies, anti-rabbit IgG-peroxidase conjugate, strcpmvidin-peroxidase 
conjugate and WGA-Sepharose were from Sigma. Monoclonal anti- 
bodies against GFAP were purchased from Bochringer. Antiserum 
against the purified rat brain glutamate transporter molecule was 
gencrnted in rabbits as previously described [9]. Membrane filters OE 
67 were from Schlcicher and Schucll. All other rcagcnts were of the 
purest grade commercially available. 
2.2. Mellloa!s 
2.2.1 Ccl1 culture 
Primary cultures of mouse cortical nstrocytcs were obtained from 
two-day-old BALB/c mice essentially as describe? [IO]. Cells were 
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Fig. 1. Comparison of ion-dependence and effect of ionophorcs on glulamatc transport of aslroglial (A) and synaplosomal (13) membrane vesicles. 
The transport of I PCi Ls[“H]glutamate was measured for the indicated time period, using membrane vesicles at 20 pg protein per time point. 
Mrmbrtinc vesicles wcrc prcloaded with internal medium (0.32 M munnilol. 0.12 M KP,, pH 6.8,0.5 mM K-EDTA, I mM M&SO.,) and incubated 
in external solution containing: 0.15 M LiCl (A), 0.15 M NaNOl (\7 or 0.15 M NaCl (o), Internal potassium was substituied by 0. I M Tris-HCI, 
pH G.S (v). The following ionophores were added immediately before starting the cxpcrimcnt by addition of the vesicles to the external medium 
(0.15 M NaCI, 0.32 M mannhal): none (o), _. 7 5 yM valinomycin (o), 5 /lM nigericin (m), 5 PM CCCP (0). Error bars indicate + SD (12 ;2 4 sets 
of triplicate). 
grown on poly-o-lysine (50 mg/l) coaled 250 ml culture flasks at 37°C 
in a moist atmosphere containing 5% CO?. Cultures were fed twice a
week with Dulbccco’s Modified Eagle’s Medium (high glucose formu- 
lation) supplemented with 10% fetal calf serum, 2 mM glutamine, 2.4 
g/l sodium bicarbonate and 100 mg/l gentamycin. I  these cell cultures 
flat polyclonal GFAP-positive cells described astype I astrocytes [I I] 
represented more than 95% of the ccl1 population. 
2.2.2. Preparation of astroglial membrane vesicles 
After 3 weeks in culture cells were washed with 0.32 M mannitol and 
I mM K-EDTA pH 7.4 and harvested with a rubber policeman. 
Subsequently they were homogenized on ice in 0.12 M potassium 
phosphate huffcr, pi+ 6.8, containing 0.32 M mannitol, I mM M&SO4 
and 0.5 mM K-EDTA (homogenization bull&) and centrifuged for 
IO min at 1,000 x g to remove nuclei and undisrupted cells. The 
supernatanr was cenlrifugcd for 20 min at 27,000 xg al 4°C The 
resulting pellet was suspended and diluted in 5 mM Tris-HCI and I 
mM K- EDTA, pH 7.4. After the osmotic shock, the membranes were 
collected by centrifuging at 27,000 x g for 20 min. The pellet was 
resuspended in homogenization buffer, divided into aliquots and fro- 
zen in liquid nitrogen. Under these conditions transport activity of the 
membrane vesicles was smblc at least 3 months. 
2.2.3. Preparation of synaptosomes 
Synaptosomes wcrc prepared essentially as described by Booth and 
Clark [12] with the following modifications. After removal from the 
disconlinous Ficollisucrose gradient, synaptosomes were diluied in 
0.32 M mannitol, I mM K-EDTA and 10 mM Tris/HCI, pH 7.4, and 
centrifuged at 5.500 xg for IO min to remove Ficoll. The washed 
synoplosomes were osmotically shocked as in the case of astroglial 
membriine vesicles, subsequenlly resuspended in homogeniizalion 
buffer, frozen in liquid nitrogen and stored in aliquots at -70°C. 
2.2.4. Transport assay 
Astroplial or synaptosomal membrane vesicles were loaded with the 
desired internal medium during vesicle preparation. Subsequently, 
20 ~1 (l-2 mg/ml) of membrane vesicles were diluted ai room tempcr- 
nturc into the rcspectivc external solulion supplemented with 1 @i of 
L-[“l-l]glutamic a id. The composition of internal and external media 
varying for each experiment arc given in the legends to the figures and 
tables. In the inhibition experiments L-[‘H]glulamalc and inhibitors 
were added simultaneously. The uptake assay was terminated by rap- 
idly fihcring on cellulose acetate fillers (0.45 pm), which were quickly 
rinsed with 20 vols. of ice-cold stopping solution (0.32 M mannitol and 
0. I5 M N&I). Uptake rates were corrected for background and Ieak- 
age (i.e. uptake at OOC). Experiments were done at least in triplicate. 
3.2.5 Immunolluorescence 
Cultures were fixed and permuabilizcd in ethanol/acetic a id (l9:l 
v/v) for 5 min ai -2OOC. Alier several wcl5lv2s with MEM-HEPES and 
MEWHEPES containing 1% bovine serum albumin, cells were se- 
qucntially incubated for 30 min at room temperatu= with the anti- 
body against he purified L-glutamate ransporter from rat brain (di- 
luted I:70 in MEM.BSA) and with a monoclonal anti-GFAPantibody 
16 
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Fig. 2. Compctitivc inhibition of astroglial (A) and synaptosoma! (B) L-[‘H]glutamate transport by L-rrcljs-PDC. Lincwmver-Burk plot of 
L-glutamate (V = nmol L-glutamaldmin 8mg of protein; S = PM glutamate). Transport was measured by using 30 ,ug of membrane protein per 
time point will1 1 ,uCi of L-[‘I-I]glulamale and unlabcicd L-gluiamair between 2 and 100 PM. Triplicate of mcasurcmcnts for astrcglial or 
synaptosomal mcmbranc vesicles were taken in the linear range of uptake (OS min) at 25°C in the abscncc and prcscnec io = none. l = 5 PM. 
q = IOpM, A = 25 NM) or L-IKUIS-PDC. Lines were dctermincd by linear rcgrcssion and yielded Kn, and Vm. for astrological membrane vcsiclcs 
(I .S ,uM and 4.9 nmol/minmg of prolcin) and synaplasomal tncmbranc vesicles (IO flM and 7.2 nmol/minmg of protein). (C) The Ki values for 
L-rruns-PDC of astroglial (0, 1.G PM) and synaplosonial (0, 3.5 ,uM) membrane vesicles were determined by a rcplot of the slopes. (D) The 
L-w~wPDC effect on aslroglial (0) and synaptosomal (0) glutamate transport was compared, The transport reaction was tcrminatcd after 1 min 
in the prcscna of the indicated linal concentration of the substrate anuloguc, using 50 yg of mcmbranc vesicle protein per time point and I yCi 
t_-[‘H]glutamatc. 
(diluted l:5). After four washes in MEM-BSA the secondary antibody 
mixture (FITC-conjugated goat anti-mouse IgG and TRlTC-conju- 
gated goat anti-rabbit IgG. both diluted I:50 in MEM-BSA) was 
added for 30 min. Aftrr rinsing in MEM-BSA preparations wcrc 
mounted in gevatol and cxamincd in an Olympus IMT2 invcrtcd 
microscope. 
2.2.6. Chromatography on wheat germ agglutinin-Sepharosc (WGA) 
WGAmchromatography was done essentially as described [13]. 
2.2.7 Other methods 
SDS/PAGE [I41 was done with 48 stacking and 10% separating el 
(0.5 mm thick). Tmmunoblottingwas done essentially s dcscribcd [15]. 
For immunoblot analysis eparated proteins wcrc transfcrrcd to nhro- 
cellulose membrzncs (Western blot technique). after incubation with 
13.3% gelatine and 0.05% Twccn 20 (v/v) at room tempcraturc for 30 
min to block nonspceilic binding sites the nitrocellulose strips were 
treated (overnight, 4°C) with anti-glutamate ransporter antibodies 
(1:3,000). After the next blockingstcp the secondary antibody (perox- 
idasc conjugated goat anti-rabbit IgG, diluted 1:3.000) was added for 
30 min at room tempcraturc. The thoroughly rinsed blots weredcvcl- 
opcd with the Amcrsham ECL-Detection kit and the antibody rcac- 
tion de&ted by chcmiluminesecncc using Hyperfilm-ECL. Protein 
determination was done according to the Bradford method [IG]. 
2.2.8. Internal volume of the mcmbranc vcsiclcs 
Volume determination of membrane vesicles was done essentially 
as dcscribcd [17]. The internal volume for [3H]t.-glutamate was found 
to be 2.3 2 0.29 PUmg of protein for astroglial and 2.5 2 0.34 ,Wmg 
of protein for synaptosomal membrane vesicles. If the dctcrmination 
was done with [‘H]o-glucose a internal volume of 3.7 -+ 0.4@hng or 
protein for astroglial and 3.3 + 0.36puVmg of protein for syna:tosomal 
membrane vesicles were dctermincd. 
3. RESULTS AND DISCUSSION 
The uptake characteristics of L-[3H]glutamate into 
membrane vesicles derived from cultured astrocytes or 
17 
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cortical mouse synaptosomes are illustrated by Fig. 1. 
Both astroglial as well as synaptosomal membrane ves- 
icles, loaded with potassium phosphate and diluted into 
NaCl containing medium accumulated glutamate in a 
time-dependent and saturable manner. Replacement of 
either external sodium by lithium or internal potassium 
by Tris* ions led to a complete inhibition of uptake in 
both cases. When external chloride was substituted by 
nitrate, on the other hand, no change in transport activ- 
ity was observed. In the presence of the ionophore ni- 
gericin, which collapses Na*- and IV-ion gradients, the 
astroglial and synaptosomal glutamate uptake was 
strongly diminished. With the potassium-specific iono- 
phore valinomycin present in the external medium, an 
approximately 50% stimulation was noted. Since under 
the experimental conditions chosen here valinomycin is 
expected to enhance the membrane potential, the astro- 
glial as well as the synaptosomal transport appear to be 
electrogenic processes. This is in confirmation with the 
inhibitory effect observed after addition of the proton 
conductor CCCP which in turn will diminish the mem- 
brane potential. 
Furthermore Lineweaver-Burk analysis revealed K, 
and V,,,,, values of 1.8pM and 4.9 nmollmin~mg) for the 
astroglial glutamate uptake, whereas for the synap- 
tosomal membrane preparation a K, of 7.5 PM and a 
Table I 
Inhibition of L-glutmr?ate uptake by substrate analopues 
Compound (25 ,uM) L-[‘HIglutamate uptake (% of control) 
Astro,glinl Synaptosomal 
membrane vesicles membrane vesicles 
Control 100 100 
(K,,, 1.8 ,uM + 0.4) (K,, 7.5 PM f 0.8) 
D-Aspartale 52f4 62 ?z s 
g 2;” ? 0.3)* (Ki 3.6 f 0.6)’ 
L-Aspartate 
(Ki’o.5S * 0.09) 
53 r 4 
(Ki 3.4 r 0.3) 
DL-ThEC+ 
hydroxy-aspnrtate 49 a 2 2s 2 4 
(K, I .4 P 0.2) (Kj I.9 1 0.4) 
or-Aspartate-p- 
hyroxomate 89 f 3 82 2 S 
(6 87.8 ? 1.4)’ (K, 18.9 f O.S)* 
Dihydrokainate lOTt_3 10226 
D-Glutamate 98 f 4 97 f 5 
Quisqualate 10423 I00 + 4 
Prcloaded (0.32 M mannitol, 0.12 M KP,, pH 6.8, 0.5 mM K-EDTA, 
1 mM MgSO,) astroglial and synaptosomal membrane vesicles were 
simultaneously incubaled with 20 PM unlnbeled L-glutana~e (in addi- 
tion with 1 PCi L.-[‘H]glulamate) and substrate analogucs (25,~M) far 
I min at 25OC in external solution (0.32 M mannitol, 0.15 M NaCI). 
The uptake dnta presented is reported us mean % of control P S.R. 
(n a 4 sets of triplicate). The values (FM) for K, (slope inhibition 
constants) were computed from experimental data similar to that in 
Fig. 2, fitted 10 the equation for linear compethive inhibidon (Linc- 
weaver-Burk plot). Symbols indicate: + = competitive or * = non- 
competitive inhibition of L-glutamate uptake, 
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Fig. 3. Ymmunoreactivity of total astroglial and synaptosomal mem- 
brane proteins and N-acetyl-o-glucosamine (NAG) cluatc lkom the 
WGA column. (A) Membrane vesicles of comparable transport activ- 
ity from cultured astrocytes (lane 1) and synaptosomes (lane 2) were 
subjected to SDS-PAGE and immunoblatted with anti-rat ghuamate 
transporter antiserum. (E) NAG eluate of the WGA column ol’nstro- 
cyies (lane I), synaptosomcs (lane 3) and astroglial non-WGA binding 
proteins (‘flow-through fraction’) (lane 2) were loaded per each lane 
with 0.2 fig of protein and subseqwnt!y immunoblotted with anti-rat 
glutamate transporter antiserum. 
V,,, value of 6.7 nmolimi’n~mg were determined, indi- 
cating a 4-fold higher affinity of the astrocytic L-gluta- 
mate transporter for its physiological substrate (Fig. 2A 
and B). The reported K,.,, and V,,,,,, values were deter- 
mined from the average of 4-6 experiments, while the 
plots shown in Fig. 2 are from a single representative 
experiment. 
Hence in their basic features the glutamate uptake 
systems described here are quite similar to those previ- 
ously found in astrocyte cultures [7], brain slices [I 81 or 
crude rat brain membrane preparations [6]. 
In order to allow for a more precise pharmacological 
comparison between the neuronal and glial giutamate 
transporter, a variety of synthetic glutamate analogues 
were tested in parallel. Each of the compounds was 
employed without preincubation and at low concen- 
trations (~25 ,uM), to ensure physiological competition 
with the glutamate binding site. t-rrctns-Pyrrolidine-2,4- 
dicarboxylate (L-rruns- PDC) a recently synthesized glu- 
tamate analogue, which is known to selectively inhibit 
synaptosomal glutamate transport but not to interfere 
with glutamate receptor binding [19], inhibited the as- 
troglial and synaptosomal glutamate uptake in a dis- 
tinctive manner (Fig. 2). In ihe case of synaptosomal 
membrane fractions a half-maximal inhibition was al- 
ready achieved by about 5 AM L-truns-PDC whereas in 
astroglial membrane vesicles as much as 25 ,uM of this 
glutamate analogue was necessary to yield the same 
effect (Fig. 2D). Lineweaver-Burk plots (shown in Fig. 
2A and 13) clearly demonstrate the concentration-de- 
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Fig. 4. Double labeling immunostainingol’cultured mouse astrocytes 
using anti-rat glutamate transporter antiserum (A) in conjunction with 
monoclonal anti-GAP antibodies (B) and phase contrast views (C). 
Scale bars 18ym. 
pendent effect of L-trans-PDC on either transporter, 
reflecting competitive inhibition in both cases. The Ki 
values for L-truns-PDC determined by a replot of the 
slopes gave a value of 1.6 ,uM for the astroglial gluta- 
mate transport and of 3.3 ,uM for the synaptosomal 
glutamate transport, respectively (Fig. 2C). The corre- 
sponding ratios of J&,/K, demonstrate a 24fold higher 
affinity of L-truns-PDC for the synaptosomal than for 
the astroglial glutamate transporter. Interestingly dihy- 
drokainate, which differs from L-truns-PDC only by the 
4-isopropyl and the 3-carboxymethyl side chain, neither 
showed an inhibitory effect on the astroglial nor on the 
synaptosomal g utamate transport at these low levels of 
concentration. The inhibitory effect of dihydrokainate 
previously reported by others, was measured only in the 
presence of excessively high amount of this agent 
[20,21]. Furthermore L-aspartate and DL-threo-hy- 
droxy-aspartate exhibited opposing effects (Table I), 
while the astroglial transporter reacted much more den- 
sitively with L-aspartate its synaptosomal counterpart 
interacted more strongly with DL-aspartatc-j?-hy- 
dsoxamate were quite distinct for the astroglial and syn- 
aptosomal glutamate uptake. While both compounds 
acted as competitive inhibitors on the synaptosomal 
transport in the case of glial glutamate uptake. 
K, as well as K,, were affected, indicating a linear 
non-competitive inhibition. Since DL-aspartate-/?-hy- 
droxamate is a racemate, it is possible that each of the 
two stereoisomers might inhibit the transporter differ- 
ently. Quisqualak, a putative inhibitor of Cl--depend- 
ent glutamate uptake [22-231, and D-glutama?e in con- 
trast had no effect on the sodium- and potassium- 
dependent neuronal or glial glutamate uptake system 
studied here. On the basis of the calculated Ki values 
given in Table I the following rank order of inhibition 
capacity of the analogues for the astroglial glutamate 
uptake is suggested: L-aspartate (Ki 0.55 PM) > L-tram- 
PDC (Kizl.1 PM E DL-three-&hydroxy-aspartate (KiZ
1.4 PM) > D-asparute (Ki: 2.9 ,uM) > DL-aspartate-j?- 
hydroxamate (K1 = 87.8 PM). For the synaptosomal 
glutamate transport the rank order of inhibition was 
determined as follows: DL-threo-fl-hydroxy-aspartate 
(Ki = 1.9 ,uM) z L-trans-PDC (Ki = 2.1 yM) r L-aspar- 
Pate (K* = 3.4 PM) 2 D-aspartale (Ki = 3.6 PM) > 
DL-aspartate#-hydroxamate (Ki = 18.9 AM). 
As a whole, our data imply that the astroglial and 
synaptosomal glutamate transporter from mouse cere- 
bral cortex exhibit significant structural differences in 
their glutamate binding site, whilst appearing more or 
less identical in their ion dependence. Considering this, 
it is quite conceivable that the regional heterogeneity 
recently observed for the pharmacological features of 
L-glutamate transport in the brain of rat 1193 could at 
least partly be attributed to varying proportions of the 
glial and neuronal glutamate transport system in differ- 
ent brain areas. 
Comparative immunoblot analysis of mouse astro- 
glial membrane proteins using polyclonal antibodies 
raised against the glial glutamate transporter of rat 
brain [9] showed a strongly immunoreactive band at 
about 75 kDa (Fig. 3A, lane l), which is very close to 
the value reported for the purified rat brain transporter 
19 
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[13]. This compound was highly enriched in the WGA- 
binding glycoprotcin fraction, containing the glutamate 
transport activity (Fig. 3B, lane l), whereas the non- 
WGA-binding proteins (flow-through fraction) of as- 
troglial membranes, exhibiting only a *break transport 
activity were just faintly immunolabeled (Fig. 3B, lane 
2). In the synaptosomal membrane protein fraction an 
immunostsined band of corresponding electrophoretic 
mobility was revealed too (Fig. 3A, lane 2; and B, lane 
3). This could be due tc a glial contamination of the 
synaptosomal membrane preparation, but we cannot 
exclude the possibility of some immunological 
crossreactivity with a neuronal form of the glutamate 
transporter or the presence of a common molecular 
subunit. Accordingly it could be envisaged that the 
transport activity of the neuronal glutamate carrier in 
the synaptosomal membrane preparation was partly 
masked by those of the glial carrier. Kcnce it is likely 
that the pharmacological differences between both 
transporter subtypes described here on a molecular level 
may be even more pronounced. It is also conceivable 
that differences in the microenvironment of both trans- 
porters might have contributed to the divergent phar- 
macological behaviour. It is worth mentioning in this 
context hat in the case of the neuronal and glial GABA- 
transport system two proteins with distinct pharmacol- 
ogical and even antigenic properties were revealed 
f24,25]. 
Double-labeling immunostaining of cultured cortical 
mouse astrocytes using monoclonal anti-GFAP anti- 
bodies in conjunction with the above-mentioned poly- 
clonal anti-rat glutamate transporter antiserum re- 
vealed that virtually all of the astrocytes were intensely 
labelled with the anti-glutamate ransporter antiserum; 
typically the immunofluorescence was not homogene- 
ously distributed over the plasma membrane but exhib- 
ited an irregularly arranged patchy network of staining. 
In future a detailed comparison of the two glutamate 
transporter molecules on the level of cDNA-sequencing 
will be necessary to yield more precise information as 
to the molecular structures underlying the divergent 
pharmacology of either glutamate carrier. 
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